MOBP and amyotrophic lateral sclerosis: Together with prior evidence of promoter hypermethylation and reduced expression in MSA, our findings identify cg15069948 as a regulatory methylation site linking ALS/PSP risk variants to altered <i>MOBP</i> methylation, and support <i>MOBP</i> dysregulation as a shared feature of neurodegeneration.